Oct 30 (Reuters) -
IMMUNO BIOLOGICAL LABORATORIES CO LTD
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Full year to Full year ended
Sep 30, 2009 Sep 30, 2008 Mar 31, 2010 Mar 31, 2009
LATEST YEAR-AGO COMPANY YEAR-AGO
H1 RESULTS H1 RESULTS FORECAST RESULTS Sales 448 mln 525 mln 1.03
(-14.7 pct) (-0.6%) Operating loss 173 mln loss 191 mln loss 190 mln Recurring loss 171 mln loss 196 mln loss 195 mln Net loss 171 mln loss 205 mln loss 215 mln EPS loss Y277.77 loss Y333.07 loss Y348.80 Shares 616,400 616,400 Annual div nil nil -Q2 div nil nil -Q4 div nil nil
NOTE - Immuno Biological Laboratories Co Ltd is the full company name.
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half dividend and Q4 to the second-half dividend announced before a new corporate law in 2006 allowed companies to pay and report dividends on a quarterly basis.
For latest earnings estimates made by Toyo Keizai, please double click on 4570.TK1.